Kazia Therapeutics (ASX:KZA) General and Admin. Expense : A$8.86 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Kazia Therapeutics General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Kazia Therapeutics's General and Admin. Expense for the six months ended in Dec. 2023 was A$4.56 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$8.86 Mil.

Kazia Therapeutics General and Admin. Expense Historical Data

The historical data trend for Kazia Therapeutics's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kazia Therapeutics General and Admin. Expense Chart

Kazia Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

General and Admin. Expense

Get a 7-Day Free Trial

3.79

3.69

7.02

5.11

8.58

Kazia Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
General and Admin. Expense	Get a 7-Day Free Trial															2.48	2.63	4.28	4.31	4.56

Kazia Therapeutics General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$8.86 Mil.

Kazia Therapeutics General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Kazia Therapeutics's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Kazia Therapeutics (ASX:KZA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (ASX:KZA) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

KZIA:USA

Address

300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000

Website

https://www.kaziatherapeutics.com

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Kazia Therapeutics (ASX:KZA) Headlines

No Headlines